The haemoglobinopathies are prevalent genetic disorders in Nigeria, it is therefore imperative that diagnosis is made accurately and promptly so that affected individuals can seek timely medical help. There is no structured modality for the investigation of the haemoglobinopathies in the country. Haemoglobin electrophoresis at alkaline pH is solely relied upon by both the secondary and tertiary health centres in the diagnosis of the haemoglobinopathies. It is also necessary to know and understand the various diagnostic tests available for this genetic disorder and to interpret the results cor-rectly. This review discusses the different diagnostic tests appropri-ate for the different levels of health care in the country.
INTRODUCTION
The haemoglobinopathies are a group of inherited disorders of haemoglobin synthesis and are divided into five broad groups which include, structural (quali-tative), quantitative (Thalassaemias), unstable haemoglobins, haemoglobins with low oxygen affinity and the M haemoglobins which are associated with familial cyanosis while haemoglobins with high oxygen affinity are associated with erythrocytosis (polycythaemia). Accurate diagnosis of the haemoglobinopathies is necessary in this environment not because it is a prevalent condition but also because even though there are over 400 haemoglobin variants not all are symptomatic. Most haemo-globinopathies are due to one or two amino acid substitutions thus affecting the mobility of the haemoglobin on electrophoresis. This aids easy diagnosis of these disorders. There are a number of clinically significant haemoglobins which do not alter the overall charge of the protein so are detected by other methods other than electrophoresis, e.g. isoelectric focusing, high-performance liquid chromatography (HPLC), and immunologic techniques.
Sickle cell disease (SCD) is a haemoglobinopathy with structural defect and it is very common in Nigeria. The prevalence of homozygous SCD (HbSS) and HbS+C disease is 3.1% and 1.1% respectively thus giving a combined prevalence of 4.1% while the trait (HbAS) has a prevalence of 23.7%
1 . This high preva-lence requires that accurate diagnosis of the disorder is made, not only at the tertiary hospitals but also at the secondary level while primary health centres should be able to screen patients for the disorder.
The thalassaemias are quantitative disorders of haemoglobin synthesis which are classified into two; the alpha and the beta thalassaemias. The single deletion alpha thalassaemia which is common 2 in this environ-ment is the mild type but beta thalassaemia which is of more clinical significance was initially thought to be of low prevalence 3 but it is now known to be of high prevalence 4, 5 . There is therefore the need to be able to differentiate these various haemoglobinopathies and treat the patients' accordingly. Accurate diagnosis will also prevent subjecting the patients to unnecessary investigations.
The objective of this write up is to provide a guideline for the screening and diagnosis of the haemoglobinopathies in the Nigerian setting and to delineate what tests are appropriate for the different level of health care.
Patient Selection
Patients who present with unexplained anaemia should be screened for haemoglobinopathy and it should be mandatory to rule out a haemoglobinopathy especially in patients presenting with moderate or severe anaemia in the presence of jaundice 5 . Patients noticed to have microcytosis and hypochromia on blood film review, should be investigated for thalassaemia more so if a trial of iron therapy does not correct this blood film appearance. The nation is however ripe for newborn screening of these prevalent disorders; this will help in reducing the morbidity and mortality associated with them. Solubility test: This is based on the fact that HbS is less soluble than HbA in the deoxygenated state. One drop of the patient's blood is mixed with a solution pre-pared using potassium dihydrogen phosphate, dipo-tassium hydrogen phosphate and sodium metabisulphite. The mixture is spun in a centrifuge; HbS if present, precipitates as a red opaque band on the surface of the test solution while other haemoglobins remain in solution 6 . Control blood samples with HbA, HbAS and HbS should be tested at the same time. There are commercial test kits now available for this procedure. Solubility test should be performed on all samples which showed the "S" band on alkaline electrophoresis especially in our environ-ment in which haemoglobins G and D which comigrate with HbS on alkaline electrophoresis is present.
Haemoglobin Electrophoresis
In an alkaline buffer, HbA is a negatively charged pro-tein which moves toward the positive electrode (an-ode) in an electric field. Most haemoglobin variants are separated from HbA during electrophoresis be-cause the structural abnormality usually involves changes in electrical charge while haemoglobin with-out a change in charge will not separate. The pH and medium used are varied in order to identify the dif-ferent haemoglobin variants; electrophoresis for hae-moglobin identification is commonly run with cellu-lose acetate paper at alkaline pH and/or citrate agar at acidic pH.
Cellulose acetate electrophoresis at alkaline pH : Cellulose ac-etate paper as support medium and at a pH of 8. Isoeletric focusing: This is a high resolution method for separating proteins according to their isoeletric points, i.e. points at which the net charge is zero. Separation of haemoglobins by this method is similar to that obtained by electrophoresis on cellulose acetate ex-cept that the bands are sharper and the resolution of some haemoglobins are better.
Diagnosis of the Thalassaemias
Red cell indices are particularly useful in screening for the thalassaemias and this is best done by an auto-mated blood cell counter. Beta thalassaemia trait (BTT) is associated with mild or no anaemia but with re-duced mean corpuscular volume (MCV), mean cor-puscular haemoglobin (MCH), values and an elevated haemoglobin A2 (HbA2) level 7, 8 , normal red cell indi-ces may however be found in people withα + thalassaemia trait 9 or silentβ + trait 7 . The diagnosis of αthalassaemia is often made following exclusion ofβ thalassaemia and/or iron deficiency; since most cases of alpha thalassaemia are of the clinically benign type (i.e. α + thalassaemia). It should be noted that the red cell indices may also be affected by concomitant B12 deficiency, folate deficiency or liver abnormalities with such people having normal red cell indices. Also in the Nigerian population where the prevalence of alpha thalassaemia is equally high, normal red cell indices does not rule out Beta thalassaemia trait since there may not be the expected alpha/ beta chain imbalance.
To make a diagnosis of thalassaemia trait therefore, the following tests should be done (a) electrophoresis of haemoglobin on cellulose acetate membrane at al- 
HB H inclusion bodies:
The presence of Hb H inclusion bodies is better observed in slides prepared from fresh blood stained with supravital stains like brilliant cresyl blue or new methylene blue and it indicative of alpha thalassaemia. Red cells with inclusion bodies are fewer in people with alpha thalassaemia trait than in people with Hb H disease. The absence of Hb H inclusion does not, however, exclude an alpha thalassaemia trait.
Iron status:
Iron deficiency anaemia is a differential diagnosis of hypochromic, microcytic anaemia; it can also be a reason for a low HbA 2 in a patient with beta thalassaemia trait. It may therefore be necessary to know the iron status of a patient suspected of having thalassaemia trait. Red cell indices and formulae derived from them have not been useful in differentiat-ing between beta thalassaemia trait and iron deficiency 8, 14, 15 . Studies done in the Nigerian population have shown normal iron levels in healthy, pregnant women and sickle cell disease patients 16,17 so hypochromic microcytic cells in peripheral blood film review should not be assumed to be due to iron deficiency when iron studies have not been done.
Globin Chain Synthesis :
This technique quantifies the amount of alpha and beta chains (α/β ratio) by culturing peripheral blood reticulocytes in the presence of tritiated leucine. It helps to determine if there is an imbalance in the ratio of synthesis of the two globin chains. This test is better done in a reference laboratory with facilities for the use and disposal of radioactive materials. The ratio is less than one in alpha thalassaemia and greater than one in beta thalassaemia. 
CONCLUSION
Primary health care facilities are closest to the communities; so should be able to screen for the haemoglobinopathies. Therefore, every patient presenting with a haematocrit less than 30% should be referred for secondary care, so also should all patients found to have a positive sickling test. These centres should have facilities to check the haematocrit of patients and a microscope for the sickling test. The staff should be trained to use the microscope for a sickling test and to check for hypochromia and microcytosis. Every general hospital on the other hand should be able to run electrophoresis at alkaline pH and have an automated cell counter to check the red cell indices of patients. Staff at these hospitals should also be able to interpret results from both equipment. While at the tertiary level, citrate agar electrophoresis or isoelectric focusing should be mandatory with DNA technol-ogy provided at designated tertiary centres in the geopolitical zones. Accurate diagnosis of the haemoglobinopathies is important in this community with a high prevalence of the sickle cell and thalassaemia syndromes. Each hospital should have technical staffs that are well trained to handle the specimens and should be able to decide when to refer diagnosis to a higher facility when difficulty arises. The need for quality control is also essential in the diagnosis of the haemoglobinopathies; apart from the inbuilt quality control of each procedure, laboratories should be a part of other external quality control programs.
